Kbc Group Nv Harmony Biosciences Holdings, Inc. Transaction History
Kbc Group Nv
- $32.2 Billion
- Q1 2025
A detailed history of Kbc Group Nv transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 1,844 shares of HRMY stock, worth $55,246. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,844
Previous 1,844
-0.0%
Holding current value
$55,246
Previous $63,000
3.17%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HRMY
# of Institutions
265Shares Held
45.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$198 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$175 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$142 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$47.4 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.45MShares$43.4 Million2.2% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.77B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...